EQRx

EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…

EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in…

EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…

Turning Point Therapeutics and EQRx Announce Clinical Collaboration to Evaluate Elzovantinib in Combination with Aumolertinib…

EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…

Collaboration leverages AbCellera’s AI-powered technology platform to identify novel antibody drug candidates for multiple disease…

Collaboration combines Exscientia’s leading AI-driven drug discovery capabilities and EQRx’s innovative development and commercialization model…

EQRx, a company committed to developing and delivering important new medicines at lower prices, along…

Aumolertinib Significantly Prolongs Progression-Free Survival with Fewer Side Effects in the First-Line Treatment of Patients…